pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Denali Therapeutics Inc. ($DNLI) · news · pharmadog
← back to Denali Therapeutics Inc.
News mentioning $DNLI
10
stories
Oct 16, 26
Lilly interested in ibogaine investments, its neuro leader says
endpoints
Sep 28, 26
‘We’re so close to the tech companies’: Genentech CEO talks Fierce through vision for the future
fiercebiotech
Sep 28, 26
AbbVie wins FDA approval for Parkinson’s drug from $8.7B Cerevel takeover
biospace
Sep 16, 26
5 biotechs braving the commercial waters with product launches
biospace
Sep 8, 26
Reeling from past failures, Parkinson's pipeline enters 'era of diversification'
biospace
Aug 10, 26
Denali climbs past Avlayah expectations with $3.6M in revenue
biospace
Jul 30, 26
Biogen validated the Alzheimer’s tau theory. CEO Viehbacher still isn’t betting the store
biospace
Jul 14, 26
Biogen data highlight promise, questions surrounding tau-targeting Alzheimer’s drugs
biopharma dive
Jun 18, 26
Pfizer CFO to step down; Denali sells a regulatory fast-pass
biopharma dive
Dec 22, 25
Fierce Biotech Fundraising Tracker '26: VitriVax scores $87M; Ansa adds $71.5M series C
fiercebiotech